Flashblood
Flashblood is a term used to describe the practice of sharing blood between intravenous drug users, often with the intention of sharing the drug that may remain in the blood. This practice is particularly dangerous due to the high risk of transmitting blood-borne diseases, such as HIV and hepatitis C.
Overview[edit | edit source]
Flashblood is a practice that has been reported in various parts of the world, including Africa, Asia, and North America. It is often associated with poverty and drug addiction, as it is a method used by individuals who cannot afford to purchase drugs on their own.
The term "flashblood" comes from the method used to share the blood. After one person injects a drug, they draw some of their own blood back into the syringe, creating a mixture of blood and residual drug. This mixture, or "flashblood", is then injected by another person.
Health Risks[edit | edit source]
The practice of sharing flashblood carries significant health risks. The most serious of these is the transmission of blood-borne diseases. HIV and hepatitis C are both commonly spread through sharing needles and other drug paraphernalia, and the risk is even higher when sharing blood directly.
In addition to the risk of disease transmission, flashblood can also lead to other health complications. These can include infection, overdose, and damage to the veins and arteries.
Prevention and Treatment[edit | edit source]
Efforts to prevent the practice of flashblood often focus on harm reduction strategies. These can include providing access to clean needles and syringes, offering drug rehabilitation programs, and educating individuals about the risks associated with sharing blood.
Treatment for individuals who have engaged in flashblood typically involves testing for and treating any blood-borne diseases they may have contracted. This can include antiretroviral therapy for HIV and antiviral medications for hepatitis C.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
